⌘K
Loading ticker…
As of 2026-08-24, Eton Pharmaceutcials, Inc. Common Stock (ETON) has a 3-month relative strength percentile of 98 and a leadership percentile of 99 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 95. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.7%, relative volume 1.18×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ETON is in a stage 2 uptrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 51.0% / 144.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
ETON is held by 15 ETFs as of May 2026. Top owner: VTWO at 0.02% weight, $4M notional. Top 3 carry $6M.
Held by 24 ETFs · $55M across latest filings · largest weight 0.21% (ACSG).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $68K |
| — |
| IBBQ | 0.06% | $43K | +0.03 pp |
| ITWO | 0.02% | $37K | — |
| ACSG | 0.21% | $37K | new |
| BIB | 0.04% | $30K | +0.02 pp |
Showing 10 of 15 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ETON Jan avg: 12.88% median: 15.01% win: 75% σ: 19.37% n: 4 2022-04-12 → 2026-07-31 | ETON Feb avg: 1.12% median: 1.24% win: 50% σ: 11.08% n: 4 2022-04-12 → 2026-07-31 | ETON Mar avg: 3.86% median: -6.26% win: 50% σ: 29.14% n: 4 2022-04-12 → 2026-07-31 | ETON Apr avg: 1.56% median: -5.71% win: 20% σ: 15.91% n: 5 2022-04-12 → 2026-07-31 | ETON May avg: 7.00% median: 9.09% win: 80% σ: 14.73% n: 5 2022-04-12 → 2026-07-31 | ETON Jun avg: -7.74% median: -11.87% win: 20% σ: 16.17% n: 5 2022-04-12 → 2026-07-31 | ETON Jul avg: 4.02% median: 2.29% win: 60% σ: 17.17% n: 5 2022-04-12 → 2026-07-31 | ETON Aug avg: 23.48% median: 25.01% win: 75% σ: 30.85% n: 4 2022-04-12 → 2026-07-31 (current) | ETON Sep avg: 10.39% median: 9.23% win: 50% σ: 20.42% n: 4 2022-04-12 → 2026-07-31 | ETON Oct avg: 11.67% median: 11.31% win: 75% σ: 25.19% n: 4 2022-04-12 → 2026-07-31 | ETON Nov avg: 12.93% median: 4.05% win: 50% σ: 34.67% n: 4 2022-04-12 → 2026-07-31 | ETON Dec avg: 5.07% median: 1.58% win: 50% σ: 13.28% n: 4 2022-04-12 → 2026-07-31 |